Suppr超能文献

贝斯特卵黄样黄斑营养不良中的双侧连续性脉络膜新生血管形成

Bilateral consecutive choroidal neovascularization in Best vitelliform macular dystrophy.

作者信息

Hoyek Sandra, Lin Lisa Y, Kozek Lindsay Klofas, Gonzalez Efren, Rajabi Farrah, Patel Nimesh A

机构信息

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

Proc (Bayl Univ Med Cent). 2022 May 5;35(4):562-564. doi: 10.1080/08998280.2022.2071075. eCollection 2022.

Abstract

Best vitelliform macular dystrophy (BVMD) is a slowly progressive macular disease caused by a pathogenic variant of the Bestrophin () gene. Examination coupled with multimodal imaging and genetic testing are used to guide diagnosis and treatment. A 12-year-old girl was examined for decreased vision in the left eye and showed bilateral "egg-yolk"-like macular lesions with choroidal neovascularization (CNV) in the left eye. Six months later, she experienced decreased vision with appearance of CNV on optical coherence tomography angiography in the right eye. Injections of anti-vascular endothelial growth factor helped restore vision from 20/125 to 20/20 in the right eye with stabilization of her left eye (vision 20/40). Genetic testing revealed c.851A > G (p.Tyr284Cys), a heterozygous variant of the gene. The same variant was found in her father, who was initially misdiagnosed with toxoplasmosis due to a peripheral retinal lesion in the left eye. This is the first report of bilateral consecutive CNV secondary to BVMD. Additionally, it highlights the likely pathogenic role of a novel variant of the gene.

摘要

最佳卵黄样黄斑营养不良(BVMD)是一种由Bestrophin()基因的致病变异引起的缓慢进展性黄斑疾病。结合多模态成像和基因检测的检查用于指导诊断和治疗。一名12岁女孩因左眼视力下降接受检查,结果显示双眼有“蛋黄”样黄斑病变,左眼伴有脉络膜新生血管(CNV)。六个月后,她右眼视力下降,光学相干断层扫描血管造影显示右眼出现CNV。注射抗血管内皮生长因子使右眼视力从20/125恢复到20/20,左眼视力稳定在20/40。基因检测发现基因的一个杂合变异c.851A > G(p.Tyr284Cys)。在她父亲身上也发现了相同的变异,其父亲最初因左眼周边视网膜病变被误诊为弓形虫病。这是首例继发于BVMD的双侧连续性CNV报告。此外,它突出了基因一种新变异可能的致病作用。

相似文献

1
Bilateral consecutive choroidal neovascularization in Best vitelliform macular dystrophy.
Proc (Bayl Univ Med Cent). 2022 May 5;35(4):562-564. doi: 10.1080/08998280.2022.2071075. eCollection 2022.
5
Optical coherence tomography angiography in best vitelliform macular dystrophy.
J Curr Ophthalmol. 2019 Jul 16;31(4):442-445. doi: 10.1016/j.joco.2019.06.005. eCollection 2019 Dec.
6
RECURRENCE OF VITELLIFORM LESIONS ASSOCIATED WITH TEMPORARY VISION LOSS IN BEST VITELLIFORM MACULAR DYSTROPHY.
Retin Cases Brief Rep. 2016 Winter;10(1):63-71. doi: 10.1097/ICB.0000000000000207.
7
ADULT-ONSET VITELLIFORM MACULAR DYSTROPHY SECONDARY TO A NOVEL IMPG2 GENE VARIANT.
Retin Cases Brief Rep. 2021 Jul 1;15(4):356-358. doi: 10.1097/ICB.0000000000000824.
8
Intravitreal bevacizumab treatment for exudative choroidal neovascularisation in best vitelliform macular dystrophy.
Eur J Ophthalmol. 2021 Nov 13:11206721211057684. doi: 10.1177/11206721211057684.
9
Clinical findings in eyes with BEST1-related retinopathy complicated by choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1125-1137. doi: 10.1007/s00417-021-05447-y. Epub 2021 Oct 18.
10
"Novel p.Tyr284Cys BEST1 genotype-phenotype correlations of Vitelliform Macular Dystrophy in a family with incomplete penetrance".
Ophthalmic Genet. 2020 Apr;41(2):183-188. doi: 10.1080/13816810.2020.1744020. Epub 2020 Mar 24.

引用本文的文献

1
Best Vitelliform Macular Dystrophy Presenting with Choroidal Neovascular Membrane in an Adolescent: A Case Report and a Review of the Literature.
J West Afr Coll Surg. 2025 Apr-Jun;15(2):240-242. doi: 10.4103/jwas.jwas_12_24. Epub 2024 Jul 18.

本文引用的文献

1
Clinical findings in eyes with BEST1-related retinopathy complicated by choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1125-1137. doi: 10.1007/s00417-021-05447-y. Epub 2021 Oct 18.
2
"Novel p.Tyr284Cys BEST1 genotype-phenotype correlations of Vitelliform Macular Dystrophy in a family with incomplete penetrance".
Ophthalmic Genet. 2020 Apr;41(2):183-188. doi: 10.1080/13816810.2020.1744020. Epub 2020 Mar 24.
3
Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Int J Mol Sci. 2020 Feb 26;21(5):1597. doi: 10.3390/ijms21051597.
4
Neovascularized Best Disease in Child: Contribution of Optical Coherence Tomography Angiography.
Ophthalmic Surg Lasers Imaging Retina. 2019 Sep 1;50(9):597-601. doi: 10.3928/23258160-20190905-11.
5
Multimodal imaging in Multifocal Best disease.
Indian J Ophthalmol. 2018 Sep;66(9):1313-1315. doi: 10.4103/ijo.IJO_70_18.
6
Optical coherence tomography angiography characterisation of Best disease and associated choroidal neovascularisation.
Br J Ophthalmol. 2018 Apr;102(4):444-447. doi: 10.1136/bjophthalmol-2017-310586. Epub 2017 Aug 1.
7
HORMONAL SUPPLEMENTATION TRIGGERING CHOROIDAL NEOVASCULARIZATION IN HEALTHY YOUNG FEMALES.
Retin Cases Brief Rep. 2019;13(2):162-166. doi: 10.1097/ICB.0000000000000549.
8
Best's macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations.
Eye (Lond). 2011 Feb;25(2):208-17. doi: 10.1038/eye.2010.180. Epub 2010 Nov 26.
9
Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.
Indian J Ophthalmol. 2010 Mar-Apr;58(2):160-2. doi: 10.4103/0301-4738.60096.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验